ACR Advises Changes to Washington State PAD Report
ACR urged the WA State Health Technology Clinical Committee to not act on the draft report that would limit coverage of endovascular procedures for PAD.
Read moreMain Content
FDA Releases Final Guidance For MQSA Regulation Changes Effective Sept. 10
Aug. 29, 2024
The U.S. Food and Drug Administration (FDA) this week provided notice of final guidance issued by the Center for Devices and Radiological Health, Mammography Quality Standards Act (MQSA) and Regulation Amendments: Small Entity Compliance Guide (SECG). The FDA developed the SECG to explain the actions a small entity must take to comply with the MQSA rule and its implementing regulations.
The March 2023 MQSA rule modernized mammography regulations and specifies that the mammography report given to patients specifies if they have dense or non-dense breast tissue; it includes a prescribed paragraph on the significance of breast density.
The FDA prepared the SECG to help small entities comply with MQSA regulation changes, which take effect Sept. 10.
For more information, contact Katie Grady, American College of Radiology® Government Affairs Director.
The March 2023 MQSA rule modernized mammography regulations and specifies that the mammography report given to patients specifies if they have dense or non-dense breast tissue; it includes a prescribed paragraph on the significance of breast density.
The FDA prepared the SECG to help small entities comply with MQSA regulation changes, which take effect Sept. 10.
For more information, contact Katie Grady, American College of Radiology® Government Affairs Director.
Related ACR News
ACR Releases Impact Tables for 2026 MPFS Proposed Rule
The tables cover specific proposed changes in reimbursement rates between 2025 and 2026 for each CPT® code.
Read moreTake Action: Contact Your US Senators to Cosponsor ROOT Act
Support the ROOT Act—Senate cosponsors needed to fix CMS issues with imaging AUC under PAMA. College member advocacy is key.
Read more